Results 141 to 150 of about 576 (158)

Amélioration des performances de la collecte des CPA sur Trima Accel

Transfusion Clinique et Biologique, 2015
Objectif L’objectif principal de ce travail est d’ameliorer les performances de productivite et de securite du prelevement par apherese de notre equipe de collecte. L’objectif secondaire associe a ce travail est d’instaurer chez notre equipe une dynamique d’amelioration continue a travers le suivi des indicateurs qualite.
I. Frigaa, I. Bounaas, S. Rezzagui, H. Ouelaa   +3 more
openaire   +1 more source

Frequency and specificity of the Trima Accel “verify WBCs” advisory: considerations for product management

Transfusion, 2011
BACKGROUND: The Trima Accel displays a “verify WBCs” message if the plateletpheresis product (PLT) may not be leukoreduced (LR). Most blood banks require sensitive white blood cell (WBC) testing of these PLTs by flow or Nageotte. We evaluated how often these PLTs were non‐LR by European or US Food and Drug Administration (FDA) criteria and whether ...
Susan A, Galel, Juliana, Gaitan, Darlene T, Yu, Lorna, Tolentino, Jan, Webster, Elaine, Sugasawara, Jo Ann, Wilson, Cynthia, Boone, Patricia, Lendio   +8 more
openaire   +2 more sources

Comparison of plateletpheresis on the Fenwal Amicus, Fresenius COM.TEC, and Trima Accel Cell separators

Journal of Clinical Apheresis, 2014
Blood component donations by apheresis have become more common in modern blood transfusion practices. We compared three apheresis instruments (Fenwal Amicus, Fresenius COM.TEC, and Trima Accel) with regard to platelet (PLT) yield, collection efficiency (CE), and collection rate (CR). The single‐needle or double‐needle plateletpheresis procedures of the
ÖZTÜRK, Ahmet, Solmaz, Musa, Yay, Mehmet, Keklik, Muzaffer, KAYNAR, Leylagül, Sivgin, Serdar, ÇETİN, Mustafa, Buyukoglan, Rüksan, Keklik, Ertuğrul, ESER, Bülent, Unal, Ali   +10 more
openaire   +3 more sources

First comparison of productivity and citrate donor load between the Trima® version 4 (dual‐stage filler) and the Trima Accel® (single‐stage filler) in the same donors

Vox Sanguinis, 2003
Background and Objectives  Aside from new software the blood cell separator TRIMA (GambroBCT) also received a newly designed separation chamber offering a novel single stage separation technology, called Trima Accel. We evaluated this new system focusing on productivity and donor comfort by comparing it to the previous version (Trima version 4) in ...
J, Ringwald, J, Zingsem, R, Zimmermann, E, Strasser, M, Antoon, R, Eckstein   +5 more
openaire   +2 more sources

A comparative study of five plateletpheresis machines in a tertiary care center of India: AmiCORE vs COM.TEC vs Haemonetics MCS+ vs Spectra Optia vs Trima Accel

Journal of Clinical Apheresis, 2020
AbstractBackgroundSingle donor apheresis platelets are superior in quality, but their usage is limited in a developing country due to cost and time constraints. Hence the product obtained must exceed in terms of yield, donor safety and technical convenience.
Priyadarsini Jayachandran Arcot, Karan Kumar, Poonam Coshic, Vijay Andriyas, Vikas Mehta   +4 more
openaire   +2 more sources

Postdonation platelet counts are safe when collecting platelets with the Trima Accel using a postdonation platelet count target of ≥50,000 platelets/μL

Journal of Clinical Apheresis, 2009
AbstractIn December 2007, the FDA issued a guidance document recommending that apheresis cell separators be configured with a postdonation platelet count target of ≥100,000 platelets/μL. Currently, our Trima Accel apheresis cell separators are configured with a postdonation platelet count target of ≥50,000 platelets/μL.
Jessie, Alex, Beverly, Roberts, Thomas, Raife   +2 more
openaire   +2 more sources

An in vitro pilot study of apheresis platelets collected on Trima Accel system and stored in T‐PAS+ solution at refrigeration temperature (1‐6°C)

Transfusion, 2019
BACKGROUNDUsing platelet additive solution (PAS) to dilute fibrinogen during long‐term cold storage of platelets (PLTs) decreases PLT activation and increases functional PLT shelf life. We performed a randomized, paired study to assess the in vitro quality of PLTs stored in the cold in T‐PAS+ for up to 18 days evaluated against PLTs stored under ...
Kristin M. Reddoch‐Cardenas, Umang Sharma, Christi L. Salgado, Robbie K. Montgomery, Carolina Cantu, Neslihan Cingoz, Ron Bryant, Daniel N. Darlington, Heather F. Pidcoke, Robin M. Kamucheka, Andrew P. Cap   +10 more
openaire   +2 more sources

A Prospective Comparative Study of High‐Yield Plateletpheresis Using Haemonetics MCS +, Trima Accel, and Spectra Optia Devices in a Resource‐Constrained Setting

Journal of Clinical Apheresis
ABSTRACT In a resource‐constrained setting, maximizing plateletpheresis efficiency is critical. We believe leveraging advanced apheresis device software to enhance platelet yield, reduce consumables, and shorten procedure times offers significant advantages.
Eiman Hussein, Azza A. Aboul Enein
openaire   +1 more source

[The Causes of Platelet Aggregation in Version 6.4 Trima Accel Automated Blood Collection System and the Comparison of Two Intervention Measures].

Zhongguo shi yan xue ye xue za zhi
To explore the causes of platelet aggregation in version 6.4 Trima Accel automated blood collection system and the effect of 2 intervention measures.The data on platelet aggregation (n=61) and non-aggregation (n=323) of 61 donors in 2020 were collected and the causes of aggregation were analyzed.
Shu-Ming, Huang, Xiao-Mei, Lin, Hui-Wei, Tang, Jia, Zeng   +3 more
openaire   +1 more source

Comparison of plateletpheresis on the Fenwal Amicus, Fresenius COM.TEC, and Trima Accel Cell separators

Journal of Clinical Apheresis, 2015
Muzaffer Keklik, Leylagul Kaynar, Ertugrul Keklik   +2 more
exaly